- ►annals.org JF Seymour, RF Gagel, FB Hagemeister, MA … - Annals of internal medicine, 1994 - Am Coll Physicians Objective: To determine the following: a reference range for serum calcitriol
during hypercalcemia in a control group of patients with myeloma in whom
calcitriol production is known to be appropriately suppressed; the ... Cited by 48 - Related articles - BL Direct - All 5 versions
JF Seymour, RF Gagel - Blood, 1993 - Am Soc Hematology DISTINCT SYNDROME of calcitriol (1,25-dihy- A droxyvitamin D,)-mediated
hypercalcemia is seen in patients with Hodgkin's disease and non-Hodgkin's lym-
phomas (NHL). In addition to hypercalcemia, this syn- drome is ... Cited by 91 - Related articles - BL Direct - All 5 versions
N ROSENTHAL, KL INSOGNA, J GODSALL, … - Journal of Clinical Endocrinology & Metabolism, 1985 - Endocrine Soc Three patients with hypercalcemia associated with malignant lymphoma and
elevations in plasma 1,25-dihydroxyvitamin D [1,25-(OH) 2 D] are described. In
addition to the elevation of circulating 1,25-(OH) 2 D, these three ... Cited by 66 - Related articles - All 3 versions
F Firkin, H Schneider, V Grill - Leukemia & lymphoma, 1998 - informahealthcare.com Hypercalcemia is an important complication in multiple myeloma as well as T-cell
leukemia/lymphoma, and is moderately common in high and intermediate grade non-
Hodgkin's lymphoma. The underlying mechanism has been unclear because the ... Cited by 72 - Related articles - BL Direct - All 9 versions
K Ikeda, H Ohno, M Hane, H Yokoi, M Okada, … - Journal of Clinical Endocrinology & Metabolism, 1994 - Endocrine Soc Page 1. 0021-972X/94/7905-1322$03.00/0 Journal of Clinical Endocrinology and Metabolism
Copyright 0 1994 by The Endocrine Society Vol. 79, No. 5 Printed in USA ... Cited by 41 - Related articles - BL Direct - All 4 versions
K Nakayama, S Fukumoto, S Takeda, Y … - Journal of Clinical Endocrinology & Metabolism, 1996 - Endocrine Soc Page 1. 0021-972x196/$03.00/0 Journal of Clinical Endocrinology and Metabolism
Copyright 0 1996 by The Endocrine Society Vol. 81, No. 2 Prmted in USA ... Cited by 30 - Related articles - All 6 versions
M Davies, ME Hayes, JA Yin, JL Berry, EB … - Journal of Clinical Endocrinology & Metabolism, 1994 - Endocrine Soc Page 1. 0021-972X/94/7805-1202$03.00/0 Journal of Clinical Endocrinology and Metabolism
Copyright C 1994 by The Endocrine Society Vol. 78, No. 5 Printed m U SA ... Cited by 16 - Related articles - BL Direct - All 5 versions
R Kremer, C Shustik, T Tabak, V Papavasiliou … - The American journal of medicine, 1996 - Elsevier Using the NH 2 -terminal radioimmunoassay, PTHRP concentrations in healthy
controls were undetectable (<7.5 pmol equivalents of PTHRP [fragment 1–34] per
liter). The majority of hypercalcemic patients (8/14) had non-Hodgkin's ... Cited by 44 - Related articles - BL Direct - All 5 versions
[CITATION] Hypercalcemia, hypercalciuria, and elevated serum 1, 25-dihydroxyvitamin D …
D Thiebaud, AF Jacquet, P Burckhardt - Archives of Internal Medicine, 1990 - archinte.highwire.org \s=b\Seventeen patients with malignant hypercalcemia were treated with a
combination ofa singledose of 3-amino 1-hydroxy- propylidene-1-bisphosphonate
(APD [also known as AHPrBP or palmidronatedisodium])and salmon calcitonin ... Cited by 21 - Related articles - All 4 versions
